2 unknown. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Unknown 2 |
| Phase 2 | 1 | Unknown 1 |
Follow Tetanus: new trials by email Literature Review of Tetanus trials Research Report on Tetanus
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate Safety and Immunogenicity of APV006 in Healthy Adults DTaP-HepB-IPV-Hib vaccine - Diphtheria, Tetanus | Phase 1 | Unknown | LG Chem | 42 | 2023-07-17 | 2023-07-19 |
| Safety and Immunogenicity Study of Tetanus, Diphtheria and Acellular Pertussis (Tdap) Vaccine Biological: GC3111 vaccine, Biological: Boostrix® vaccine - Tetanus, Diphtheria | Phase 1 / Phase 2 | Unknown | Green Cross Corporation | 220 | 2016-06-01 | 2016-11-07 |
Diphtheria (2) · Whooping Cough (2) · Haemophilus Infections (1) · Hepatitis B (1) · Poliomyelitis (1)
Actinomycetales Infections (2) · Bacterial Infections (2) · Bacterial Infections and Mycoses (2) · Bordetella Infections (2) · Clostridium Infections (2) · Corynebacterium Infections (2) · Gram-Negative Bacterial Infections (2) · Gram-Positive Bacterial Infections (2) · Infections (2) · Respiratory Tract Diseases (2) · Respiratory Tract Infections (2) · Blood-Borne Infections (1) · Central Nervous System Diseases (1) · Central Nervous System Infections (1) · Communicable Diseases (1)
Boostrix (1)
Green Cross Corporation (1) · LG Chem (1)
South Korea (1)
Nam Joong Kim (1)